WNT4, RSPO1, and FOXL2 in sex development

Seminars in Reproductive Medicine

Volumn 30, Issue 5, 2012, Pages 387-395

  Biason Lauber, Anna ^a  

^a UNIVERSITY OF FRIBOURG   (Switzerland)

Author keywords

ovarian differentiation; RSPO1; WNT4

Indexed keywords

FOXL 2 PROTEIN; R SPONDIN 1 PROTEIN; THROMBOSPONDIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; WNT4 PROTEIN;

ARTICLE; FEMALE GENITAL SYSTEM; HUMAN; MUELLERIAN DUCT; OOCYTE; OVARY DEVELOPMENT; PROTEIN EXPRESSION; SEX DIFFERENTIATION; SEXUAL DEVELOPMENT;

ANIMALS; DISORDERS OF SEX DEVELOPMENT; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; MALE; MUTATION; OVARY; SEXUAL DEVELOPMENT; TESTIS; THROMBOSPONDINS; WNT4 PROTEIN;

EID: 84867016811     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0032-1324722     Document Type: Article

References (64)

1. McElreavey K., Vilain E., Abbas N., Herskowitz I., Fellous M. A regulatory cascade hypothesis for mammalian sex determination: SRY represses a negative regulator of male development. Proc Natl Acad Sci USA: 1993; 90 8 3368 3372
2. He X., Semenov M., Tamai K., Zeng X. LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. Development: 2004; 131 8 1663 1677
3. Nusse R. Wnts and Hedgehogs: lipid-modified proteins and similarities in signaling mechanisms at the cell surface. Development: 2003; 130 22 5297 5305
4. Pandur P., Läsche M., Eisenberg L. M., Kühl M. Wnt-11 activation of a non-canonical Wnt signalling pathway is required for cardiogenesis. Nature: 2002; 418 6898 636 641
5. Jääskeläinen M., Prunskaite-Hyyryläinen R., Naillat F., et al. WNT4 is expressed in human fetal and adult ovaries and its signaling contributes to ovarian cell survival. Mol Cell Endocrinol: 2010; 317 12 106 111
6. Jordan B. K., Mohammed M., Ching S. T., et al. Up-regulation of WNT-4 signaling and dosage-sensitive sex reversal in humans. Am J Hum Genet: 2001; 68 5 1102 1109
7. Vainio S., Heikkilä M., Kispert A., Chin N., McMahon A. P. Female development in mammals is regulated by Wnt-4 signalling. Nature: 1999; 397 6718 405 409
8. Yao H. H., Matzuk M. M., Jorgez C. J., et al. Follistatin operates downstream of Wnt4 in mammalian ovary organogenesis. Dev Dyn: 2004; 230 2 210 215
9. Merchant H. Rat gonadal and ovarioan organogenesis with and without germ cells. An ultrastructural study. Dev Biol: 1975; 44 1 1 21
10. McLaren A. Meiosis and differentiation of mouse germ cells. Symp Soc Exp Biol: 1984; 38 7 23
11. Naillat F., Prunskaite-Hyyryläinen R., Pietilä I., et al. Wnt4/5a signalling coordinates cell adhesion and entry into meiosis during presumptive ovarian follicle development. Hum Mol Genet: 2010; 19 8 1539 1550
12. Ottolenghi C., Pelosi E., Tran J., et al. Loss of Wnt4 and Foxl2 leads to female-to-male sex reversal extending to germ cells. Hum Mol Genet: 2007; 16 23 2795 2804
13. Mandel H., Shemer R., Borochowitz Z. U., et al. SERKAL syndrome: an autosomal-recessive disorder caused by a loss-of-function mutation in WNT4. Am J Hum Genet: 2008; 82 1 39 47
14. Domenice S., Corrêa R. V., Costa E. M., et al. Mutations in the SRY, DAX1, SF1 and WNT4 genes in Brazilian sex-reversed patients. Braz J Med Biol Res: 2004; 37 1 145 150
15. Biason-Lauber A., Konrad D., Navratil F., Schoenle E. JA. A WNT4 mutation associated with Müllerian-duct regression and virilization in a 46,XX woman. N Engl J Med: 2004; 351 8 792 798
16. Biason-Lauber A., De Filippo G., Konrad D., Scarano G., Nazzaro A., Schoenle E. J. WNT4 deficiencya clinical phenotype distinct from the classic Mayer-Rokitansky-Kuster-Hauser syndrome: a case report. Hum Reprod: 2007; 22 1 224 229
17. Philibert P., Biason-Lauber A., Rouzier R., et al. Identification and functional analysis of a new WNT4 gene mutation among 28 adolescent girls with primary amenorrhea and müllerian duct abnormalities: a French collaborative study. J Clin Endocrinol Metab: 2008; 93 3 895 900
18. Philibert P., Biason-Lauber A., Gueorguieva I., et al. Molecular analysis of WNT4 gene in four adolescent girls with mullerian duct abnormality and hyperandrogenism (atypical Mayer-Rokitansky-Küster-Hauser syndrome). Fertil Steril: 2011; 95 8 2683 2686
19. Kamata T., Katsube K., Michikawa M., Yamada M., Takada S., Mizusawa H. R-spondin, a novel gene with thrombospondin type 1 domain, was expressed in the dorsal neural tube and affected in Wnts mutants. Biochim Biophys Acta: 2004; 1676 1 51 62
20. Kim K. A., Kakitani M., Zhao J., et al. Mitogenic influence of human R-spondin1 on the intestinal epithelium. Science: 2005; 309 5738 1256 1259
21. Chassot A. A., Gregoire E. P., Magliano M., Lavery R., Chaboissier M. C. Genetics of ovarian differentiation: Rspo1, a major player. Sex Dev: 2008; 2 45 219 227
22. Chassot A. A., Ranc F., Gregoire E. P., et al. Activation of beta-catenin signaling by Rspo1 controls differentiation of the mammalian ovary. Hum Mol Genet: 2008; 17 9 1264 1277
23. Parma P., Radi O., Vidal V., et al. R-spondin1 is essential in sex determination, skin differentiation and malignancy. Nat Genet: 2006; 38 11 1304 1309
24. Tomaselli S., Megiorni F., De Bernardo C., et al. Syndromic true hermaphroditism due to an R-spondin1 (RSPO1) homozygous mutation. Hum Mutat: 2008; 29 2 220 226
25. Crisponi L., Deiana M., Loi A., et al. The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nat Genet: 2001; 27 2 159 166
26. Cocquet J., Pailhoux E., Jaubert F., et al. Evolution and expression of FOXL2. J Med Genet: 2002; 39 12 916 921
27. Pisarska M. D., Bae J., Klein C., Hsueh A. J. Forkhead l2 is expressed in the ovary and represses the promoter activity of the steroidogenic acute regulatory gene. Endocrinology: 2004; 145 7 3424 3433
28. Pannetier M., Fabre S., Batista F., et al. FOXL2 activates P450 aromatase gene transcription: towards a better characterization of the early steps of mammalian ovarian development. J Mol Endocrinol: 2006; 36 3 399 413
29. Ellsworth B. S., Egashira N., Haller J. L., et al. FOXL2 in the pituitary: molecular, genetic, and developmental analysis. Mol Endocrinol: 2006; 20 11 2796 2805
30. Pannetier M., Renault L., Jolivet G., Cotinot C., Pailhoux E. Ovarian-specific expression of a new gene regulated by the goat PIS region and transcribed by a FOXL2 bidirectional promoter. Genomics: 2005; 85 6 715 726
31. Moumné L., Batista F., Benayoun B. A., et al. The mutations and potential targets of the forkhead transcription factor FOXL2. Mol Cell Endocrinol: 2008; 282 12 2 11
32. Henderson S. T., Johnson T. E. daf-16 integrates developmental and environmental inputs to mediate aging in the nematode Caenorhabditis elegans. Curr Biol: 2001; 11 24 1975 1980
33. Batista F., Vaiman D., Dausset J., Fellous M., Veitia R. A. Potential targets of FOXL2, a transcription factor involved in craniofacial and follicular development, identified by transcriptomics. Proc Natl Acad Sci U S A: 2007; 104 9 3330 3335
34. Smith W. L., Dewitt D. L. Prostaglandin endoperoxide H synthases-1 and -2. Adv Immunol: 1996; 62 167 215
35. Uhlenhaut N. H., Jakob S., Anlag K., et al. Somatic sex reprogramming of adult ovaries to testes by FOXL2 ablation. Cell: 2009; 139 6 1130 1142
36. Shah S. P., Köbel M., Senz J., et al. Mutation of FOXL2 in granulosa-cell tumors of the ovary. N Engl J Med: 2009; 360 26 2719 2729
37. Moumné L., Fellous M., Veitia R. A. Deletions in the polyAlanine-containing transcription factor FOXL2 lead to intranuclear aggregation. Hum Mol Genet: 2005; 14 23 3557 3564
38. Moumné L., Dipietromaria A., Batista F., et al. Differential aggregation and functional impairment induced by polyalanine expansions in FOXL2, a transcription factor involved in cranio-facial and ovarian development. Hum Mol Genet: 2008; 17 7 1010 1019
39. Dipietromaria A., Benayoun B. A., Todeschini A. L., Rivals I., Bazin C., Veitia R. A. Towards a functional classification of pathogenic FOXL2 mutations using transactivation reporter systems. Hum Mol Genet: 2009; 18 17 3324 3333
40. Benayoun B. A., Georges A. B., L'Hôte D., et al. Transcription factor FOXL2 protects granulosa cells from stress and delays cell cycle: role of its regulation by the SIRT1 deacetylase. Hum Mol Genet: 2011; 20 9 1673 1686
41. Liang L., Soyal S. M., Dean J. FIGalpha, a germ cell specific transcription factor involved in the coordinate expression of the zona pellucida genes. Development: 1997; 124 24 4939 4947
42. Rajkovic A., Pangas S. A., Ballow D., Suzumori N., Matzuk M. M. NOBOX deficiency disrupts early folliculogenesis and oocyte-specific gene expression. Science: 2004; 305 5687 1157 1159
43. Soyal S. M., Amleh A., Dean J. FIGalpha, a germ cell-specific transcription factor required for ovarian follicle formation. Development: 2000; 127 21 4645 4654
44. De La Chesnaye E., Kerr B., Paredes A., Merchant-Larios H., Méndez J. P., Ojeda S. R. Fbxw15/Fbxo12J is an F-box protein-encoding gene selectively expressed in oocytes of the mouse ovary. Biol Reprod: 2008; 78 4 714 725
45. Su Y. Q., Sugiura K., Wigglesworth K., et al. Oocyte regulation of metabolic cooperativity between mouse cumulus cells and oocytes: BMP15 and GDF9 control cholesterol biosynthesis in cumulus cells. Development: 2008; 135 1 111 121
46. Di Pasquale E., Rossetti R., Marozzi A., et al. Identification of new variants of human BMP15 gene in a large cohort of women with premature ovarian failure. J Clin Endocrinol Metab: 2006; 91 5 1976 1979
47. Dixit H., Rao L. K., Padmalatha V. V., et al. Missense mutations in the BMP15 gene are associated with ovarian failure. Hum Genet: 2006; 119 4 408 415
48. Qin Y., Choi Y., Zhao H., Simpson J. L., Chen Z. J., Rajkovic A. NOBOX homeobox mutation causes premature ovarian failure. Am J Hum Genet: 2007; 81 3 576 581
49. Palmer J. S., Zhao Z. Z., Hoekstra C., et al. Novel variants in growth differentiation factor 9 in mothers of dizygotic twins. J Clin Endocrinol Metab: 2006; 91 11 4713 4716
50. Chand A. L., Ponnampalam A. P., Harris S. E., Winship I. M., Shelling A. N. Mutational analysis of BMP15 and GDF9 as candidate genes for premature ovarian failure. Fertil Steril: 2006; 86 4 1009 1012
51. Kovanci E., Rohozinski J., Simpson J. L., Heard M. J., Bishop C. E., Carson S. A. Growth differentiating factor-9 mutations may be associated with premature ovarian failure. Fertil Steril: 2007; 87 1 143 146
52. Harris S. E., Chand A. L., Winship I. M., Gersak K., Aittomäki K., Shelling A. N. Identification of novel mutations in FOXL2 associated with premature ovarian failure. Mol Hum Reprod: 2002; 8 8 729 733
53. Britt K. L., Findlay J. K. Regulation of the phenotype of ovarian somatic cells by estrogen. Mol Cell Endocrinol: 2003; 202 12 11 17
54. Couse J. F., Hewitt S. C., Bunch D. O., et al. Postnatal sex reversal of the ovaries in mice lacking estrogen receptors alpha and beta. Science: 1999; 286 5448 2328 2331
55. Dupont S., Krust A., Gansmuller A., Dierich A., Chambon P., Mark M. Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development: 2000; 127 19 4277 4291
56. Lin L., Achermann J. C. Steroidogenic factor-1 (SF-1, Ad4BP, NR5A1) and disorders of testis development. Sex Dev: 2008; 2 45 200 209
57. Hanley N. A., Ball S. G., Clement-Jones M., et al. Expression of steroidogenic factor 1 and Wilms' tumour 1 during early human gonadal development and sex determination. Mech Dev: 1999; 87 12 175 180
58. Murayama C., Miyazaki H., Miyamoto A., Shimizu T. Involvement of Ad4BP/SF-1, DAX-1, and COUP-TFII transcription factor on steroid production and luteinization in ovarian theca cells. Mol Cell Biochem: 2008; 314 12 51 58
59. Biason-Lauber A., Schoenle E. J. Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive steroidogenic factor 1 (NR5A1/SF-1) and adrenocortical insufficiency. Am J Hum Genet: 2000; 67 6 1563 1568
60. Lourenço D., Brauner R., Lin L., et al. Mutations in NR5A1 associated with ovarian insufficiency. N Engl J Med: 2009; 360 12 1200 1210
61. Jeays-Ward K., Hoyle C., Brennan J., et al. Endothelial and steroidogenic cell migration are regulated by WNT4 in the developing mammalian gonad. Development: 2003; 130 16 3663 3670
62. Kocer A., Reichmann J., Best D., Adams I. R. Germ cell sex determination in mammals. Mol Hum Reprod: 2009; 15 4 205 213
63. Combes A. N., Spiller C. M., Harley V. R., et al. Gonadal defects in Cited2-mutant mice indicate a role for SF1 in both testis and ovary differentiation. Int J Dev Biol: 2010; 54 4 683 689
64. Tomizuka K., Horikoshi K., Kitada R., et al. R-spondin1 plays an essential role in ovarian development through positively regulating Wnt-4 signaling. Hum Mol Genet: 2008; 17 9 1278 1291